Breast Implant Lawsuits: Breast Implant-Associated Anaplastic Large Cell Lymphoma
Commonly asked questions about Breast Implant-Associated Anaplastic Large Cell Lymphoma:
- What is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)?
- Do Breast Implants Cause Cancer?
- What Types of Breast Implants Cause Cancer?
- What are the Symptoms of Breast Implant-Associated Anaplastic Large Cell Lymphoma?
- How is Breast Implant-Associated Anaplastic Large Cell Lymphoma Treated?
- What are the Criteria For Filing a Breast Implant Cancer Lawsuit?
- Can I File a BIA-ALCL Lawsuit?
- Our No-Fee Promise on BIA-ALCL Cases
- How Do I Start a Breast Implant Cancer Claim?
What is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)?
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma that can develop following breast implants.
Lymphoma is a cancer of the immune system. It refers to the cancer of lymphocytes, special white blood cells that fight infection. Lymphocytes are present in abundance in the thymus, spleen, bones, and lymph nodes, but can be present anywhere in the body, and thus, the cancer can form in any part of the body.
In cases of breast implant-associated cancer, anaplastic large cell lymphoma appears in the tissue capsule surrounding the implant.
Do Breast Implants Cause Cancer?
As of February 1, 2017, the FDA has received a total of 359 medical device reports of breast implant-associated anaplastic large cell lymphoma. That includes nine reported deaths caused by BIA-ALCL.
The FDA states that the risk factors of BIA-ALCL potentially include the methods used to create surface texture of the implant and the role of biofilm in the implant.
This type of cancer is very rare, however. According to the American Society of Plastic Surgeons and the Plastic Surgery Foundation, out of the 10 million women who have received breast implants worldwide, fewer than 10 cases of BIA-ALCL are diagnosed each year. One study estimates that one in 300,000 women are diagnosed.
Overall, current studies suggest that women with breast implants have a low but increased risk of developing anaplastic large cell lymphoma as compared to women who do not have breast implants.
What Types of Breast Implants Cause Cancer?
Studies on BIA-ALCL suggest that the surface type and the fill type of the implant may affect the development of the cancer.
Of the 359 cases of BIA-ALCL reported to the FDA, 231 included information on the implant’s surface type:
- 203 were textured surface implants
- 28 were smooth surface implants
312 of the 359 reports included information on implant fill type:
- 186 contained a silicone gel fill type
- 126 contained a saline fill type
While the data on type of implant is limited, it does suggest that breast implant-associated anaplastic large cell lymphoma occurs more frequently with textured implants than smooth-surface implants. Researchers have not yet identified an underlying reason for this association.
BIA-ALCL is associated with both saline filled breast implants and silicone gel breast implants
What are the Symptoms of Breast Implant-Associated Anaplastic Large Cell Lymphoma?
Symptoms of BIA-ALCL include the following:
- Persistent swelling in the breast area
- Persistent pain in the breast area
- Fluid collection in the breast area
If you develop these symptoms of BIA-ALCL, it is essential that you contact your physician immediately.
How is Breast Implant-Associated Anaplastic Large Cell Lymphoma Treated?
In many cases, BIA-ALCL can be treated by removing the implant and the capsule surrounding the implant. Some patients, however, may require chemotherapy and radiation to treat the cancer.
The FDA recommends that breast implant recipients follow standard medical recommendations, including following your doctor’s instructions on how to monitor the implants. Mammograms should be routinely scheduled, as well as MRIs if the implants are silicone gel-filled.
If you detect any changes around the implant site, contact your doctor immediately so that if BIA-ALCL is present, treatment is immediate.
What are the Criteria For Filing a Breast Implant Cancer Lawsuit?
If you underwent surgery to receive breast implants and later developed BIA-ALCL and its symptoms, you may be entitled to compensation from the implant manufacturer.
The criteria for filing a breast implant cancer lawsuit include the following:
- Must be diagnosed with breast implant-associated anaplastic large cell lymphoma
- If unsure of diagnosis, consultation with the client’s physician may be necessary. A biopsy can give a definitive diagnosis.
- May have experienced symptoms of BIA-ALCL including swelling, pain, and fluid collection in the breast area
- Implant does not have to still be in place
Can I File a BIA-ALCL Lawsuit?
Our dangerous device attorneys can help you if you were harmed by breast implant-associated cancer.
We have the experience necessary to take on powerful medical device manufacturers and get you the compensation you deserve. Our top-rated lawyers are handling litigation nationwide and are currently accepting new BIA-ALCL cases in all 50 states.
We do not charge any legal fees unless you receive a settlement, and we pay all of the case costs.
When we take on a case, we handle it from start to finish so that you can focus on healing.
Our No-Fee Promise on BIA-ALCL Cases
You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started.
We promise you in writing:
- No money to get started
- We pay all case costs and expenses
- No legal fees whatsoever unless you receive a settlement
- Phone calls to our office are always free
How Do I Start a Breast Implant Cancer Claim?
Our BIA-ALCL lawyers will help you file your lawsuit. To get started, you can:
- Submit the Free Case Review Box on this page, or
- Call (866) 280-3417 any time of day to tell us about your case.
We will listen to your story and answer your questions. If you have claim, we will start immediately.
WARNING: There are strict time deadlines for filing breast implant-associated cancer lawsuit claims.